查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1990300

內視鏡閉合裝置市場：2026-2032年全球市場預測（依產品類型、閉合機制、材料、應用及最終用戶分類）

Endoscopic Closure Devices Market by Product Type, Closure Mechanism, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內視鏡閉合裝置市場價值將達到 5.7077 億美元，到 2026 年將成長至 6.0204 億美元，到 2032 年將達到 8.6462 億美元，複合年成長率為 6.11%。

主要市場統計數據
基準年 2025 570,770,000 美元
預計年份：2026年 6.0204億美元
預測年份 2032 8.6462億美元
複合年成長率 (%) 6.11%

不斷提高的臨床期望、技術協同效應以及相關人員的經濟因素如何重新定義內視鏡閉合裝置市場的優先事項。

在臨床需求和器械創新共同推動下，內視鏡閉合裝置已從輔助器具發展成為治療性內視鏡工作流程的核心組成部分。隨著微創手術範圍和複雜性的增加，臨床醫生需要可預測且持久的閉合解決方案，以降低併發症率、縮短恢復時間並擴大內視鏡介入治療的適用人群。能源來源、成像系統和配套工具包的進步正在影響器械的形狀和手術通訊協定，促使製造商重新評估設計重點，例如輸送方式、易用性和與現有內視鏡的兼容性。

臨床領域的擴展、整合設備平台的整合以及對實證監管的重視，正在重塑競爭重點和產品藍圖。

近年來，臨床實務、技術整合和法律規範都發生了變革性變化，這些變化共同重塑了內視鏡閉合裝置的格局。臨床上，內視鏡手術範圍的不斷擴大，從高級止血和穿孔處理到肥胖症治療性介入，推動了對多功能閉合解決方案的需求，這些解決方案需能可靠地應用於各種組織類型和手術情況。這促使人們增加對輸送系統、材料科學和使用者介面設計的技術投入，旨在減少植入差異並擴大適應症。

關稅政策的波動促使企業進行策略性供應鏈多元化、近岸外包舉措，並重新評估整個設備組合的採購經濟效益。

隨著美國將於2025年實施新的關稅措施，製造商和醫療保健供應商的供應鏈和產業計畫將變得更加複雜。關稅調整可能會影響進口零件和成品的到貨成本，因此需要重新評估籌資策略和成本轉嫁決策。為此，醫療設備開發商和經銷商正在審查其採購流程，以確保關鍵手術用品的供應連續性，同時盡可能減少利潤率的下降。

進行詳細的細分分析，以確定每種醫療設備類型、臨床環境、作用機制和材料考量的明確需求促進因素。

觀點分析揭示了每種產品類型、最終用戶、應用、閉合機制和材料的不同需求促進因素和創新路徑。產品分類包括夾子、密封劑和縫合線，每種分類包含各自獨特的亞型，具有各自獨特的臨床應用。夾子分為金屬和聚合物兩種類型；金屬夾子通常用於持久的機械固定，而聚合物夾子則常用於減少偽影並提高在特定組織類型中的貼合度。密封劑包括生物衍生的纖維蛋白製劑和合成黏合劑。纖維蛋白基產品因其生物相容性和止血效果而備受青睞，而合成黏合劑提供針對特定應用的固化特性和操作性能。縫合線分為可吸收縫合線和不可吸收縫合線；可吸收縫合線為癒合提供可吸收的組織支撐，而不可吸收縫合線則在需要長期組織暴露時提供持續的抗張強度。

區域趨勢和醫療保健系統優先事項的差異正在決定封閉式技術採用途徑和打入市場策略的多樣化。

區域趨勢影響內視鏡閉合裝置的創新、應用和商業策略，美洲、歐洲、中東和非洲以及亞太地區呈現出截然不同的模式。在美洲，先進科技的應用和一體化醫療服務網路為那些展現出高效操作和明確治療效果的裝置創造了機會。同時，控制成本的壓力和支付方的嚴格審查促使人們更加關注循證醫學的產生以及整個醫療過程的整體價值。該地區的法規結構和報銷環境尤其重視可靠的臨床數據和清晰的手術編碼系統。

競爭格局的特點是：成熟企業利用規模優勢，敏捷的創新者，以及優先考慮基於證據、服務和系統層面價值的協作策略。

該行業的競爭格局由成熟的醫療設備製造商、細分領域的專業公司和靈活的Start-Ups組成，它們在創新和市場准入方面各有優勢。老字型大小企業通常利用規模、分銷網路和綜合臨床支援項目，確保其產品在高流量手術中心獲得成功部署。這些企業通常會投資於產品改進、廣泛的臨床試驗以及全面的培訓課程，以降低跨學科團隊部署的障礙。

為製造商和供應商提供切實可行的策略措施，以使產品開發、證據產生和供應彈性與不斷變化的臨床需求保持一致。

產業領導企業可以採取一系列切實可行的措施來應對臨床、商業性和營運方面的複雜挑戰，同時加速推廣有效的閉合解決方案。首先，他們可以透過使研發投資與可驗證的臨床需求保持一致，提高高頻手術場所的採用率，例如提高在發炎組織內部署的可靠性，以及實現在狹窄解剖結構內進行低輪廓輸送。優先考慮以使用者為中心的設計，並投資於基於模擬器的訓練模組，可以縮短學習曲線，並提高治療的一致性，而無需考慮操作者的技能水平。

為確保研究結果具有可操作性和檢驗，我們採用了嚴格的混合研究框架，該框架結合了主要臨床發現、監管審查和供應鏈映射。

本分析所依據的研究採用混合方法，旨在產生可靠且可操作的見解，同時保持透明度和可重複性。主要研究包括對第一線內視鏡醫師、外科負責人、採購負責人和設備開發人員進行深度訪談，以了解他們對臨床需求、設備性能和採購決策者的原有觀點。這些定性資訊與設備使用手冊、監管申報文件和同行評審的臨床文獻進行交叉比對，以檢驗性能聲明並識別證據缺口。

隨著技術、臨床和營運重點的融合，不斷發展的血管閉合裝置市場的成功被認為取決於綜合的、以證據主導的策略。

內視鏡閉合裝置的未來發展將受到臨床創新、實證醫學需求和操作需求三者共同影響。隨著手術複雜性的增加和醫療相關人員對可驗證價值的要求日益提高，成功的器械策略需要具備以下要素：穩定的臨床表現、透過有效的教育支持推廣應用以及穩健的供應鏈。材料科學的進步、輸送機制的改進以及與內視鏡平台更緊密的整合將持續拓展其臨床效用。然而，這些技術進步必須輔以嚴謹的系統性獲益證據，才能確保其廣泛應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡閉合裝置市場：依產品類型分類

  • 夾子
    • 金屬夾
    • 聚合物夾
  • 密封劑
    • 纖維蛋白膠
    • 合成黏合劑
  • 縫合線
    • 可吸收縫線
    • 不可吸收縫線

第9章 依閉合機制分類的內視鏡閉合裝置市場

  • 黏合封口
    • 注射式黏合劑
    • 局部黏合劑
  • 機械閉合
    • 夾子已關閉
    • 縫合閉合

第10章 內視鏡閉合裝置市場：依材料分類

  • 金屬
  • 聚合物

第11章 內視鏡閉合裝置市場：依應用領域分類

  • 肥胖症治療
  • 消化系統

第12章 內視鏡閉合裝置市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章 內視鏡閉合裝置市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 內視鏡閉合器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 內視鏡閉合器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國內視鏡閉合裝置市場

第17章：中國內視鏡閉合器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Ackermann Instrumente GmbH
  • Ambu A/S
  • Apollo Endosurgery Inc
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • CONMED Corporation
  • Cook Medical LLC
  • CooperSurgical Inc
  • ENDO-FLEX GmbH
  • EndoGastric Solutions Inc
  • Ethicon Inc
  • Fujifilm Holdings Corporation
  • Hoya Corporation
  • Karl Storz SE & Co. KG
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Micro-Tech Endoscopy USA Inc
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • STERIS plc
  • Teleflex Inc
Product Code: MRR-CB04E05659AA

The Endoscopic Closure Devices Market was valued at USD 570.77 million in 2025 and is projected to grow to USD 602.04 million in 2026, with a CAGR of 6.11%, reaching USD 864.62 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 570.77 million
Estimated Year [2026] USD 602.04 million
Forecast Year [2032] USD 864.62 million
CAGR (%) 6.11%

How accelerating clinical expectations, technological synergies, and stakeholder economics are redefining priorities in the endoscopic closure device landscape

Endoscopic closure devices have moved from niche adjuncts to core components of therapeutic endoscopy workflows, driven by converging clinical needs and device innovation. As minimally invasive procedures expand in scope and complexity, clinicians require predictable, durable closure solutions that reduce complication rates, shorten recovery times, and expand the eligible patient population for endoscopic interventions. The evolution of energy sources, imaging systems, and accessory toolkits has influenced device form factors and procedural protocols, prompting manufacturers to rethink design priorities such as delivery profile, ease of deployment, and compatibility with existing endoscopes.

Concurrently, stakeholder expectations have shifted. Hospital administrators emphasize device cost-effectiveness and procedural throughput, while payers and regulators increasingly scrutinize safety evidence and real-world outcomes. These pressures are reshaping procurement criteria and catalyzing cross-disciplinary collaboration among gastroenterologists, bariatric surgeons, and interventional endoscopists. As a result, the competitive landscape now rewards suppliers who can demonstrate not only clinical efficacy but also robust training programs, service reliability, and clear value propositions tied to patient pathways.

This introduction summarizes the forces that are steering product development and commercial strategy in endoscopic closure technologies. With a sharper focus on reproducibility, ease of use, and integrated procedural solutions, the field is entering a phase where incremental device enhancements will be judged on their ability to deliver measurable improvements in clinical workflow and patient-centered outcomes.

Clinical expansion, integrated device-platform convergence, and evidence-driven regulatory emphasis are reshaping competitive priorities and product roadmaps

Recent years have seen transformative shifts across clinical practice, technology integration, and regulatory oversight that collectively reshape the endoscopic closure device landscape. Clinically, the broadening scope of endoscopic therapeutic procedures-spanning advanced hemostasis, perforation management, and bariatric interventions-has driven demand for versatile closure solutions that perform reliably across variable tissue types and procedural contexts. This has incentivized engineering investments in delivery systems, material science, and user-interface design aimed at reducing deployment variability and expanding indications.

On the technology front, improvements in visualization, navigation, and device ergonomics have enabled tighter integration between closure tools and procedural workflows. Enhanced endoscopic platforms provide higher fidelity imaging and more precise control, which in turn allow closure devices to be optimized for smaller working channels and complex anatomies. These synergies are encouraging manufacturers to pursue collaborative product roadmaps and platform-compatible accessories rather than standalone instruments.

Regulatory and reimbursement trends are also exerting influence. Agencies are increasingly focused on post-market surveillance and real-world evidence, prompting device developers to prioritize registries and clinical partnerships that can substantiate safety profiles over time. Payers are similarly attentive to longitudinal outcomes, which has elevated the importance of demonstrating reductions in readmissions, secondary interventions, and total episode-of-care costs. Together, these shifts are driving a market environment where clinical versatility, evidence generation, and system-level value are central to competitive differentiation.

Shifts in tariff policy are prompting strategic supply chain diversification, nearshoring initiatives, and reassessment of procurement economics across device portfolios

The imposition of new tariff measures in the United States for the year 2025 has injected an additional layer of complexity into supply chain and commercial planning for manufacturers and healthcare providers. Tariff adjustments can alter landed costs for imported components and finished devices, prompting reassessment of sourcing strategies and cost pass-through decisions. In response, device developers and distributors are recalibrating procurement processes to mitigate margin erosion while preserving supply continuity for critical procedural items.

Strategically, the tariff environment is accelerating two complementary responses: diversification of supplier bases and selective nearshoring of manufacturing activities. Diversification reduces single-supplier exposure and enhances resilience to customs or logistics disruptions. Nearshoring and regional production can insulate companies from tariff volatility, shorten lead times, and simplify regulatory compliance across key markets. These shifts are not purely operational; they also influence product lifecycle economics and commercial planning, including inventory policies, contractual terms with health systems, and portfolio prioritization.

From a commercial perspective, end users and group purchasing organizations are re-evaluating procurement criteria to balance total cost of ownership with clinical performance. For some stakeholders, the tariff-driven rise in import costs may accelerate adoption of domestically produced alternatives or variants that optimize material usage without compromising clinical outcomes. Overall, the tariff landscape is prompting more dynamic supply chain strategies and closer alignment between operations, regulatory affairs, and commercial leadership to safeguard access to essential closure devices.

Detailed segmentation analysis revealing distinct demand drivers across device types, clinical settings, mechanism choices, and material considerations

A granular view of segmentation exposes differentiated demand drivers and innovation pathways across product types, end users, applications, closure mechanisms, and materials. Product classifications include clips, sealants, and sutures, each with internal subtypes that have distinct clinical applications. Clips are available as metal and polymer variants, with metal clips often selected for durable mechanical fixation and polymer clips for reduced artifact and improved conformability in certain tissue types. Sealants encompass biologic fibrin formulations and synthetic adhesives, where fibrin-based products are favored for biocompatibility and hemostatic support while synthetic adhesives offer tailored curing profiles and handling characteristics. Sutures bifurcate into absorbable and non-absorbable options, with absorbable sutures providing resorbable tissue support for healing and non-absorbable sutures delivering prolonged tensile strength where extended approximation is required.

End users span ambulatory surgical centers, clinics, and hospitals, and each setting imposes distinct constraints on device selection. Ambulatory surgical centers and outpatient clinics prioritize rapid setup, ease of use, and disposability to support high throughput and predictable procedure times. Hospitals, particularly tertiary centers, value versatility, documented clinical outcomes across complex procedures, and integration with advanced endoscopic platforms. Application-driven differences also matter: bariatric procedures often demand closure solutions that can withstand altered anatomy and high tissue stress, while gastrointestinal interventions emphasize closure reliability in friable or inflamed tissue and minimization of luminal obstruction.

Closure mechanisms further categorize offerings into adhesive and mechanical approaches. Adhesive closure includes injectable and topical adhesives, where injectables facilitate internal tissue approximation in confined spaces and topical formulations provide surface sealing and complement mechanical fixation. Mechanical closure divides into clip and suture closure, with clip closure offering rapid deployment and minimal device footprint, and suture closure enabling tailored approximation for larger defects or complex geometries. Material selection-metal versus polymer-intersects with these mechanisms, influencing imaging compatibility, tissue response, and long-term biocompatibility. Understanding these segmentation layers in combination reveals pockets of clinical need and design opportunity, as well as procurement preferences across care settings.

Regional dynamics and varying healthcare system priorities are defining differentiated adoption pathways and market entry strategies for closure technologies

Regional dynamics shape innovation, adoption, and commercial strategy for endoscopic closure devices, with distinctive patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced procedural adoption and consolidated healthcare delivery networks create opportunities for devices that demonstrate operational efficiency and clear outcome advantages; conversely, cost containment pressures and payer scrutiny drive a focus on evidence generation and total episode-of-care value. The regulatory framework and reimbursement environment in this region place a premium on robust clinical data and clear procedural coding pathways.

Within Europe, Middle East & Africa, heterogeneity across national healthcare systems fosters a diverse market landscape. Western European markets often emphasize clinical guidelines alignment and centralized procurement practices, while emerging markets within the region present growth opportunities tied to capacity expansion and investments in procedural infrastructure. The regulatory and reimbursement mosaic necessitates tailored market entry strategies and flexible commercial models that reflect regional procurement norms and local evidence requirements.

Asia-Pacific exhibits a mix of rapid adoption in urban tertiary centers and expanding access in growing middle-income markets. Local manufacturing capabilities and price sensitivity influence procurement choices, while regulatory maturation in several countries increases expectations for device safety and post-market surveillance. Across all regions, strategic manufacturers balance global platform consistency with regional customization of product offerings, training programs, and pricing models to align with differing clinical practices and healthcare system priorities.

Competitive landscape characterized by scale-driven incumbents, agile innovators, and collaboration strategies that prioritize evidence, service, and system-level value

Competitive dynamics within the industry reflect a mix of established medical device manufacturers, niche specialists, and agile start-ups, each bringing different capabilities to innovation and market access. Established players often leverage scale, distribution networks, and integrated clinical support programs to secure placement in high-volume procedural centers. These organizations typically invest in incremental product improvements, broad clinical studies, and comprehensive training curricula that reduce adoption friction among multi-disciplinary teams.

Niche specialists and newer entrants frequently compete on technological novelty, focused application expertise, or cost-effective alternatives. Their strengths lie in rapid iteration, targeted clinical partnerships, and the ability to address specific unmet needs such as flexible delivery for tortuous anatomies or novel adhesive chemistries tuned for speed and biocompatibility. Collaboration between incumbents and innovators-through licensing, co-development, or acquisition-remains a common route to combine clinical credibility with technological differentiation.

Across the competitive set, value propositions are increasingly evaluated through the lens of system-level outcomes: procedural time savings, complication reduction, and compatibility with evolving endoscopic platforms. Companies that can pair compelling clinical evidence with scalable service models and supply chain resilience are better positioned to win preference among institutional buyers. Intellectual property positioning, regulatory experience, and demonstrable post-market performance form the pillars of sustained competitive advantage in this market.

Practical strategic moves for manufacturers and providers to align product development, evidence generation, and supply resilience with evolving clinical needs

Industry leaders can adopt a pragmatic set of actions to navigate clinical, commercial, and operational complexities while accelerating adoption of effective closure solutions. First, aligning R&D investments with demonstrable clinical needs-such as improving deployment reliability in inflamed tissue or creating lower-profile deliverability for tight anatomies-will improve uptake among high-volume centers. Prioritizing user-centered design and investing in simulator-based training modules can reduce learning curves and increase procedural consistency across operator skill levels.

Second, strengthening evidence generation through multi-center registries and pragmatic real-world studies will address payer and regulatory expectations for longitudinal outcomes. Embedding health economics and outcomes research into clinical programs enables stronger conversations with procurement organizations and supports differentiated reimbursement discussions. Third, rationalizing supply chains through supplier diversification, long-term contractual arrangements, and consideration of regional manufacturing can mitigate tariff exposure and logistics disruptions while improving responsiveness to demand variability.

Finally, commercial strategies should emphasize integrated offerings: combining device solutions with clinician education, procedural checklists, and post-market support enhances value perception beyond unit price. Strategic partnerships with endoscopy platform providers and clinical centers can create bundled solutions that simplify adoption. Leaders who execute these actions with cross-functional coordination among R&D, regulatory, supply chain, and commercial teams will be positioned to capture momentum as procedural volumes and clinical expectations continue to evolve.

A rigorous mixed-methods research framework combining primary clinical insight, regulatory review, and supply chain mapping to ensure actionable and validated findings

The research underpinning this analysis integrates a mixed-methods approach designed to produce robust, actionable insights while maintaining transparency and reproducibility. Primary research included in-depth interviews with practicing endoscopists, surgical leaders, procurement officers, and device developers to capture firsthand perspectives on clinical needs, device performance, and procurement decision drivers. These qualitative inputs were triangulated with device instruction for use documentation, regulatory filings, and peer-reviewed clinical literature to validate performance claims and identify gaps in evidence.

Secondary research encompassed a systematic review of clinical guidelines, regulatory announcements, and policy shifts affecting device access and post-market surveillance. Supply chain mapping drew on publicly available customs and trade data, provider procurement practices, and manufacturing disclosures to identify sourcing patterns and potential tariff sensitivities. Throughout the process, methodological rigor was maintained through standardized interview guides, thematic coding of qualitative data, and cross-checks between independent research analysts to reduce bias.

Limitations were managed through sensitivity to regional heterogeneity and the evolving regulatory environment; where variability existed, findings were contextualized with scenario-based implications rather than definitive projections. Ethical research practices guided participant engagement, and data integrity was preserved through secure handling and anonymization of primary interview material. This layered methodology ensures that conclusions reflect both practitioner realities and documented evidence, providing a sound basis for strategic decision-making.

Converging technical, clinical, and operational priorities indicate that integrated evidence-led strategies will determine success in the evolving closure device market

The trajectory of endoscopic closure devices will be shaped by the intersection of clinical innovation, evidence expectations, and operational imperatives. As procedural complexity grows and healthcare stakeholders demand demonstrable value, successful device strategies will hinge on delivering consistent clinical performance, supporting adoption with meaningful education, and maintaining resilient supply chains. Material science advances, refined delivery mechanisms, and tighter integration with endoscopic platforms will continue to expand clinical utility, but these technical gains must be accompanied by rigorous evidence of system-level benefits to secure broad adoption.

Stakeholders across the ecosystem-manufacturers, clinicians, and healthcare purchasers-stand to benefit from closer collaboration that aligns device capabilities with real-world procedural workflows and reimbursement models. Companies that invest in post-market data collection and pragmatic clinical studies will be better positioned to navigate regulatory scrutiny and payer engagement. At the same time, operational measures such as supplier diversification and regionally optimized production can reduce exposure to tariff-driven disruptions and logistics challenges.

In sum, the future of closure devices resides in the ability of market participants to marry technical innovation with practical execution: delivering solutions that are clinically credible, economically sensible, and operationally reliable will define winners in this evolving field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Closure Devices Market, by Product Type

  • 8.1. Clips
    • 8.1.1. Metal Clips
    • 8.1.2. Polymer Clips
  • 8.2. Sealants
    • 8.2.1. Fibrin Sealants
    • 8.2.2. Synthetic Adhesives
  • 8.3. Sutures
    • 8.3.1. Absorbable Sutures
    • 8.3.2. Non Absorbable Sutures

9. Endoscopic Closure Devices Market, by Closure Mechanism

  • 9.1. Adhesive Closure
    • 9.1.1. Injectable Adhesives
    • 9.1.2. Topical Adhesives
  • 9.2. Mechanical Closure
    • 9.2.1. Clip Closure
    • 9.2.2. Suture Closure

10. Endoscopic Closure Devices Market, by Material

  • 10.1. Metal
  • 10.2. Polymer

11. Endoscopic Closure Devices Market, by Application

  • 11.1. Bariatric
  • 11.2. Gastrointestinal

12. Endoscopic Closure Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Endoscopic Closure Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopic Closure Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopic Closure Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopic Closure Devices Market

17. China Endoscopic Closure Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Ackermann Instrumente GmbH
  • 18.7. Ambu A/S
  • 18.8. Apollo Endosurgery Inc
  • 18.9. B. Braun Melsungen AG
  • 18.10. Boston Scientific Corporation
  • 18.11. Cardinal Health Inc
  • 18.12. CONMED Corporation
  • 18.13. Cook Medical LLC
  • 18.14. CooperSurgical Inc
  • 18.15. ENDO-FLEX GmbH
  • 18.16. EndoGastric Solutions Inc
  • 18.17. Ethicon Inc
  • 18.18. Fujifilm Holdings Corporation
  • 18.19. Hoya Corporation
  • 18.20. Karl Storz SE & Co. KG
  • 18.21. Medtronic plc
  • 18.22. Meril Life Sciences Pvt. Ltd.
  • 18.23. Micro-Tech Endoscopy USA Inc
  • 18.24. Olympus Corporation
  • 18.25. Ovesco Endoscopy AG
  • 18.26. Richard Wolf GmbH
  • 18.27. Smith & Nephew plc
  • 18.28. STERIS plc
  • 18.29. Teleflex Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY NON ABSORBABLE SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY INJECTABLE ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY INJECTABLE ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY INJECTABLE ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY TOPICAL ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY TOPICAL ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY TOPICAL ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIP CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIP CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIP CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURE CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURE CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURE CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY BARIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY BARIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY BARIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 217. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 228. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLIPS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SEALANTS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY SUTURES, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY CLOSURE MECHANISM, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY ADHESIVE CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MECHANICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA ENDOSCOPIC CLOSURE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)